Cite
HARVARD Citation
Saydam, G. et al. (2016). Outcomes with frontline nilotinib treatment in Turkish patients with newly diagnosed Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase. Expert opinion on pharmacotherapy. pp. 1851-1858. [Online].